<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="57147">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02071433</url>
  </required_header>
  <id_info>
    <org_study_id>ACLS</org_study_id>
    <nct_id>NCT02071433</nct_id>
  </id_info>
  <brief_title>Analgesic Efficacy of Saphenous Nerve Blockade for Outpatient Knee Anterior Cruciate Ligament Surgery</brief_title>
  <official_title>Analgesic Efficacy of Saphenous Nerve Blockade for Outpatient Knee Anterior Cruciate Ligament Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</source>
  <oversight_info>
    <authority>Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)</authority>
    <authority>Netherlands: Ministry of Health, Welfare and Sport</authority>
    <authority>Netherlands: Dutch Health Care Inspectorate</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether blockade of the saphenous nerve can
      provide the same degree of analgesia postoperatively for ACLS as a femoral nerve block
      without resulting motor blockade enhancing shortening of hospital stay en functional
      outcome.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Readiness to discharge from day-care center in hours according to Post-Anesthetic Discharge Scoring System (PADSS).[</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Motor block</measure>
    <time_frame>2 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain (VAS)</measure>
    <time_frame>2 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensory blockade extent</measure>
    <time_frame>1 Day</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to rescue analgesic and post operative opioid consumption</measure>
    <time_frame>1 Day</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Benefit of Analgesia Score (OBAS)</measure>
    <time_frame>6 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-12 score</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>KOOS-score</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IKDC-score</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">58</enrollment>
  <condition>Postoperative Analgesia for Anterior Cruciate Ligament Surgery of the Knee</condition>
  <arm_group>
    <arm_group_label>Saphenous nerve blockade</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental treatment 15 mL of levobupivacaine 0.5%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Femoral nerve blockade</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard treatment 15 mL of levobupivacaine 0.5%</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Saphenous nerve blockade</intervention_name>
    <arm_group_label>Saphenous nerve blockade</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Femoral nerve blockade</intervention_name>
    <arm_group_label>Femoral nerve blockade</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18-65 years

          -  ASA status I - III

          -  rupture of the anterior cruciate ligament.

        Exclusion Criteria:

          -  contraindication for regional anesthesia

          -  allergy against local anesthetics

          -  BMI &gt; 35

          -  pre-existing diagnosed neuropathy of the operated leg

          -  ingestion of strong opioids

          -  pregnancy or breastfeeding status

          -  History of significant cardiovascular disease (MI, CVA, peripheral vascular disease)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Werner ten Hoope, MD</last_name>
    <phone>0031-205663633</phone>
    <email>w.tenhoope@amc.uva.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>M.W. Hollmann, professor dr., MD</last_name>
    <phone>0031-205663633</phone>
    <email>m.w.hollmann@amc.uva.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Academic Medical Centre Amsterdam</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 24, 2014</lastchanged_date>
  <firstreceived_date>February 24, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</investigator_affiliation>
    <investigator_full_name>W ten Hoope</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Saphenous nerve block</keyword>
  <keyword>Adductor canal block</keyword>
  <keyword>Anterior cruciate ligament</keyword>
  <keyword>Pain management</keyword>
  <keyword>Day care</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
